Ground Swell Capital’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Ground Swell Capital’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$12K	Buy	+1,521	New	+$11.8K	0.02%	846

Other funds holding VTAE

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

AWMDMG

Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ground Swell Capital's VTAE Position: Q3 2014 in Review

Ground Swell Capital opened a new position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q3 2014: 1,521 shares worth $12K. The stake represents 0.02% of the portfolio and ranks #846 among its holdings.

15 funds tracked by Wall St. Rank hold VTAE as of Q3 2014.

Ground Swell Capital held 1,521 shares of VITAE PHARMACEUTICALS INC COMMON STOCK worth $12K as of Q3 2014.
VITAE PHARMACEUTICALS INC COMMON STOCK was a new Ground Swell Capital position in Q3 2014.
VITAE PHARMACEUTICALS INC COMMON STOCK made up 0.02% of Ground Swell Capital's portfolio in Q3 2014, its #846 holding.
15 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.